LAEKNA-B (02105) completed the issue of 36 million shares of allocated shares.
Kailai Pharmaceuticals-B (02105) has announced that all conditions for the allotment have been met, and the allotment has been completed on ...
Notice from LAEKNA-B (02105): The conditions for the allotment have all been met, and the allocation was completed on September 17, 2025. According to the terms and conditions of the allotment agreement, 36 million shares have been successfully allocated to no fewer than six underwriters by the exclusive allotment agent at a price of HK$16.30 per share.
Related Articles
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
